| Literature DB >> 29248538 |
Mohammad Hassan Baig1, Mohd Adil2, Rosina Khan3, Surendar Dhadi4, Khurshid Ahmad1, Gulam Rabbani1, Tufail Bashir1, Mohammad Azhar Imran5, Fohad Mabood Husain6, Eun Ju Lee1, Mohammad Amjad Kamal7, Inho Choi8.
Abstract
Extensive growth of cancer in humans is a major cause of death. Numerous studies are being conducted to improve the early diagnosis, prevention, and treatment of cancer. Recent technological advancements in medical science and research indicate molecular target therapy holds much promise in cancer treatment. In the past, therapeutic and diagnostic targeting of non-glycolytic and glycolytic enzymes in cancer have been successful, and discoveries of biomarker enzymes in cancer hold promise for therapeutic treatments. In this review, we discuss the roles of several cancer-associated enzymes that could potentially act as therapeutic targets, and place special focus on non-glycolytic and glycolytic enzymes. This review indicates that the targeting of metabolic signaling offers a promising means of developing novel anti-cancer therapies.Entities:
Keywords: ALDH1; ALPs; Aldehyde dehydrogenase 1; Alkaline phosphatases; Biomarkers; CAT; CAXII; Cancer; Carbonic anhydrase XII; Catalase; Enzymes; G6PD; Glucose-6-phosphate dehydrogenase; Glycolysis; HKII; Hexokinase II; LDHA; Lactate dehydrogenase A; MMPs; Matrix metalloproteinases; NSE; Neurone-specific enolase; PK; Pyruvate kinase; SOD; Superoxide dismutase; Therapy; Urokinase plasminogen activator; uPA
Mesh：
Substances：
Year: 2017 PMID： 29248538 DOI： 10.1016/j.semcancer.2017.12.003
Source DB: PubMed Journal: Semin Cancer Biol ISSN： 1044-579X Impact factor: 15.707